On February 28, 2020 Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates" or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, reported that management will present a corporate overview at the Cowen & Company 40th Annual Health Care Conference, the Barclays Global Healthcare Conference, and the Oppenheimer 30th Annual Healthcare Conference (Press release, Molecular Templates, FEB 28, 2020, View Source [SID1234554979]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen & Company 40th Annual Health Care Conference
Date: Monday, March 2
Time: 3:30pm Eastern Time
Webcast: Click here for webcast

Barclays Global Healthcare Conference
Date: Wednesday, March 11
Time: 4:50pm Eastern Time

Oppenheimer & Co. 30th Annual Healthcare Conference
Date: Wednesday, March 18
Time: 1:00pm Eastern Time